Financials data is unavailable for this security.
View more
Year on year Sanofi SA grew revenues 5.49% from 44.29bn to 46.72bn while net income improved 40.52% from 5.56bn to 7.81bn.
| Gross margin | 72.07% |
|---|---|
| Net profit margin | 10.99% |
| Operating margin | 13.58% |
| Return on assets | 3.95% |
|---|---|
| Return on equity | 6.63% |
| Return on investment | 5.10% |
More ▼
Cash flow in EURView more
In 2025, Sanofi SA did not generate a significant amount of cash. However, the company earned 10.92bn from its operations for a Cash Flow Margin of 23.37%. In addition the company used 2.45bn on investing activities and also paid 8.21bn in financing cash flows.
| Cash flow per share | 3.28 |
|---|---|
| Price/Cash flow per share | 13.96 |
| Book value per share | 34.38 |
|---|---|
| Tangible book value per share | 1.84 |
More ▼
Balance sheet in EURView more
| Current ratio | 1.09 |
|---|---|
| Quick ratio | 0.7316 |
| Total debt/total equity | 0.2847 |
|---|---|
| Total debt/total capital | 0.2208 |
More ▼
Growth rates in EUR
SmartText is unavailable
| EPS growth(5 years) | -16.21 |
|---|---|
| EPS (TTM) vs TTM 1 year ago | -4.19 |
